Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homologous Reinfection with Dengue-1 or Dengue-3 Challenge
NCT05967455Phase 1Completed
- Sponsor
- Upstate Medical University
- Start
- Oct 2023
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 cohorts), sponsored by Upstate Medical University. Primary endpoints: Occurrence, Intensity, and Duration of Solicited Injection Site Symptoms at 6 days, Occurrence, Intensity, and Duration of Solicited Systemic Symptoms at 20 days and 3 more. Started Oct 2023; status: completed.
Beyond the preview
Go deeper on NCT05967455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05967455.